Levofloxacin (Quinsair®)

Assessment Status Rapid Review Complete
Drug Levofloxacin
Brand Quinsair®
Indication For the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with Cystic Fibrosis.
Assessment Process
Rapid review commissioned 10/02/2016
Rapid review completed 01/03/2016
Rapid review outcome Full pharmacoeconomic assessment recommended at the submitted price.

The HSE has approved reimbursement following confidential price negotiations.